I think they are rerating downwards so a bounce is not guaranteed...
Imm and one or two others are booking the trend...
For me SNG would be a buy @ 60p as it cannot compete with the Covid vaccines Effectiveness. Other treatments are basically just as good and have a vital head start. Imo it is a COPD drug now.
I think some biotechs will bounce but the rules have changed for me.
Angle awaiting FDA for pastorix. They have kept us well informed, just had submission accepted so looking at May 21. Looks promising and the SP once the date came out for anticipated approval. Especially with the shenanigans this week - people diving out of LTH’s to invest in Cineworld! Anyway, won’t get much cheaper than 43p so I have been loading up!
Don't look back as you are doing fine! Remember it is not about being right but making profit and I agree, Imm will deliver as will your other holdings.
Ref the RNS. I thought it was factual, not a block buster but I believe it to be a true depiction of where the FDA, Avion and Imm are at. Cant ask for more.
I am in 19 stocks and I therefore take an overview of all whilst taking a closer look when neccessary. The low share price here does not concern me for obvious reasons.
Those being: clinical approval, FDA approval and sales due next year.